3,971
Views
7
CrossRef citations to date
0
Altmetric
Review

The negative effects of obesity on heart, especially the electrophysiology of the heart

, , &
Pages 1055-1062 | Received 05 Nov 2019, Accepted 22 Feb 2020, Published online: 22 Jul 2020

References

  • Finucane MM, Stevens GA, Cowan MJ, et al. National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9.1 million participants. Lancet. 2011;377(9765):557–567.
  • Ng M, Fleming T, Robinson M, et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2014; 384(9945):766–781.
  • Schulze PC, Drosatos K, Goldberg IJ. Lipid use and misuse by the heart. Circ Res. 2016;118(11):1736–1751.
  • Messerli FH, Nunez BD, Ventura HO, et al. Overweight and sudden death. Increased ventricular ectopy in cardiopathy of obesity. Arch Intern Med. 1987;147(10):1725–1728.
  • Kannel WB, Plehn JF, Cupples LA. Cardiac failure and sudden death in the Framingham Study. Am Heart J. 1988; 115(4):869–875.
  • Fraley MA, Birchem JA, Senkottaiyan N, et al. Obesity and the electrocardiogram. Obes Rev. 2005;6(4):275–281.
  • Mutiso SK, Rono DK, Bukachi F. Relationship between anthropometric measures and early electrocardiographic changes in obese rats. BMC Res Notes. 2014;7(1):931.
  • Lepeschkin E, Surawicz B. The measurement of the Q-T interval of the electrocardiogram. Circulation. 1952;6(3):378–388.
  • Funck-Brentano C, Jaillon P. Rate-corrected QT interval: techniques and limitations. Am J Cardiol. 1993;72(6):17B–22B.
  • Omran J, Bostick BP, Chan AK, et al. Obesity and ventricular repolarization: a comprehensive review. Prog Cardiovasc Dis. 2018;61(2):124–135.
  • Ahnve S. Correction of the QT interval for heart rate: review of different formulas and the use of Bazett’s formula in myocardial infarction. Am Heart J. 1985;109(3 Pt 1):568–574.
  • Davey P. How to correct the QT interval for the effects of heart rate in clinical studies. J Pharmacol Toxicol Methods. 2002;48(1):3–9.
  • Sagie A, Larson MG, Goldberg RJ, et al. An improved method for adjusting the QT interval for heart rate (the Framingham Heart Study). Am J Cardiol. 1992;70(7):797–801.
  • Curione M, Tego A, Capoccia D, et al. Prediction of QTc length as function of BMI: a clinical tool to establish arrhythmias risk in obesity. Clin Ter. 2011;162(6):e155–159–e159.
  • Day CP, McComb JM, Campbell RW. QT dispersion: an indication of arrhythmia risk in patients with long QT intervals. Br Heart J. 1990;63(6):342–344.
  • Pye M, Quinn AC, Cobbe SM. QT interval dispersion: a non-invasive marker of susceptibility to arrhythmia in patients with sustained ventricular arrhythmias? Br Heart J. 1994;71(6):511–514.
  • Malik M, Batchvarov VN. Measurement, interpretation and clinical potential of QT dispersion. J Am Coll Cardiol. 2000;36(6):1749–1766.
  • Lehmann MH, Hardy S, Archibald D, et al. JTc prolongation with d,l-sotalol in women versus men. Am J Cardiol. 1999;83(3):354–359.
  • Tsai SF, Houmsse M, Dakhil B, et al. QTc compared to JTc for monitoring drug-induced repolarization changes in the setting of ventricular pacing. Heart Rhythm. 2014;11(3):485–491.
  • Vardar SA, Ozturk L, Altun A, et al. Ventricular repolarization in overweight and normal weight healthy young men. Anadolu Kardiyol Derg. 2008;8(1):27–31.
  • Yamaguchi M, Shimizu M, Ino H, et al. T wave peak-to-end interval and QT dispersion in acquired long QT syndrome: a new index for arrhythmogenicity. Clin Sci. 2003;105(6):671–676.
  • Kors JA, Ritsema van Eck HJ, van Herpen G. The meaning of the Tp-Te interval and its diagnostic value. J Electrocardiol. 2008;41(6):575–580.
  • Antzelevitch C, Sicouri S, Di Diego JM, et al. Does Tpeak-Tend provide an index of transmural dispersion of repolarization? Heart Rhythm. 2007;4(8):1114–1116. author reply 1116–1119.
  • Seyfeli E, Duru M, Kuvandik G, et al. Effect of weight loss on QTc dispersion in obese subjects. Anadolu Kardiyol Derg. 2006;6(2):126–129.
  • Carella MJ, Mantz SL, Rovner DR, et al. Obesity, adiposity, and lengthening of the QT interval: improvement after weight loss. Int J Obes Relat Metab Disord. 1996;20(10):938–942.
  • Gupta AK, Xie B, Thakur RK, et al. Effect of weight loss on QT dispersion in obesity. Indian Heart J. 2002;54(4):399–403.
  • Mukerji R, Terry BE, Fresen JL, et al. Relation of left ventricular mass to QTc in normotensive severely obese patients. Obesity (Silver Spring). 2012;20(9):1950–1954.
  • Mshui ME, Saikawa T, Ito K, et al. QT interval and QT dispersion before and after diet therapy in patients with simple obesity. Proc Soc Exp Biol Med. 1999;220(3):133–138.
  • Braschi A, Abrignani MG, Francavilla VC, et al. Novel electrocardiographic parameters of altered repolarization in uncomplicated overweight and obesity. Obesity (Silver Spring). 2011;19(4):875–881.
  • Pontiroli AE, Pizzocri P, Saibene A, et al. Left ventricular hypertrophy and QT interval in obesity and in hypertension: effects of weight loss and of normalisation of blood pressure. Int J Obes Relat Metab Disord. 2004;28(9):1118–1123.
  • Guo X, Li Z, Guo L, et al. Effects of metabolically healthy and unhealthy obesity on prolongation of corrected QT interval. Am J Cardiol. 2017;119(8):1199–1204.
  • Elffers TW, de Mutsert R, Lamb HJ, et al. Association of metabolic syndrome and electrocardiographic markers of subclinical cardiovascular disease. Diabetol Metab Syndr. 2017;9:40.
  • Ziegler D, Zentai C, Perz S, et al. Selective contribution of diabetes and other cardiovascular risk factors to cardiac autonomic dysfunction in the general population. Exp Clin Endocrinol Diabetes. 2006;114(4):153–159.
  • Takebayashi K, Aso Y, Sugita R, et al. Clinical usefulness of corrected QT intervals in diabetic autonomic neuropathy in patients with type 2 diabetes. Diabetes Metab. 2002;28(2):127–132.
  • Brown DW, Giles WH, Greenlund KJ, et al. Impaired fasting glucose, diabetes mellitus, and cardiovascular disease risk factors are associated with prolonged QTc duration. Results from the Third National Health and Nutrition Examination Survey. J Cardiovasc Risk. 2001;8(4):227–233.
  • Arslan E, Yiğiner Ö, Yavaşoğlu İ, et al. Effect of uncomplicated obesity on QT interval in young men. Pol Arch Med Wewn. 2010;120(6):209–213.
  • Bilora F, Vettore G, Barbata A, et al. Electrocardiographic findings in obese subjects. Minerva Gastroenterol Dietol. 1999;45(3):193–197.
  • Esposito K, Marfella R, Gualdiero P, et al. Sympathovagal balance, nighttime blood pressure, and QT intervals in normotensive obese women. Obes Res. 2003;11(5):653–659.
  • Mizia-Stec K, Mandecki T, Zahorska-Markiewicz B, et al. The QT interval dispersion and ventricular late potential in obese women. Pol Merkur Lekarski. 2000;8(44):84–86.
  • Seyfeli E, Duru M, Kuvandik G, et al. Effect of obesity on P-wave dispersion and QT dispersion in women. Int J Obes. 2006;30(6):957–961.
  • Mizia-Stec K, Mandecki T, Zahorska-Markiewicz B, et al. [QT interval dispersion and the type of obesity in women]. Pol Arch Med Wewn. 1999;101(5):391–396.
  • Corbi GM, Carbone S, Ziccardi P, et al. FFAs and QT intervals in obese women with visceral adiposity: effects of sustained weight loss over 1 year. J Clin Endocrinol Metab. 2002;87(5):2080–2083.
  • Park JJ, Swan PD. Effect of obesity and regional adiposity on the QTc interval in women. Int J Obes. 1997;21(12):1104–1110.
  • Pidlich J, Pfeffel F, Zwiauer K, et al. The effect of weight reduction on the surface electrocardiogram: a prospective trial in obese children and adolescents. Int J Obes. 1997;21(11):1018–1023.
  • Olivares Lopez JL, Vazquez Olivares M, Fleta Zaragozano J, et al. [Electrocardiographic and echocardiographic findings in children with overweight and obesity]. Med Clin (Barc). 2005;125(3):93–94.
  • Daar G, Serin HI, Ede H, et al. Association between the corrected QT interval, carotid artery intima-media thickness, and hepatic steatosis in obese children. Anatol J Cardiol. 2015;16(7):524–528.
  • Guven A, Ozgen T, Gungor O, et al. Association between the corrected QT interval and carotid artery intima-media thickness in obese children. JCRPE. 2010;2(1):21–27.
  • Lee S, Cowan PA, Wetzel GT, et al. Prediabetes and blood pressure effects on heart rate variability, QT-interval duration, and left ventricular hypertrophy in overweight-obese adolescents. J Pediatr Nurs. 2011;26(5):416–427.
  • Queen SR, Smulevitz B, Rentfro AR, et al. Electrocardiographic abnormalities among Mexican Americans: correlations with diabetes, obesity, and the metabolic syndrome. World J Cardiovasc Dis. 2012;2(2):50–56.
  • Durak A, Olgar Y, Tuncay E, et al. Onset of decreased heart work is correlated with increased heart rate and shortened QT interval in high-carbohydrate fed overweight rats. Can J Physiol Pharmacol. 2017;95(11):1335–1342.
  • Girola A, Enrini R, Garbetta F, et al. QT dispersion in uncomplicated human obesity. Obes Res. 2001;9(2):71–77.
  • Sun GZ, Li Y, Zhou XH, et al. Association between obesity and ECG variables in children and adolescents: a cross-sectional study. Exp Ther Med. 2013;6(6):1455–1462.
  • Akyuz A, Alpsoy S, Akkoyun DC, et al. Effect of overweight on P-wave and QT dispersions in childhood. Turk Kardiyol Dern Ars. 2013;41(6):515–521.
  • Carnethon MR, Prineas RJ, Temprosa M, et al. The association among autonomic nervous system function, incident diabetes, and intervention arm in the Diabetes Prevention Program. Diabetes Care. 2006;29(4):914–919.
  • Fukushige T, Yoshinaga M, Shimago A, et al. Effect of age and overweight on the QT interval and the prevalence of long QT syndrome in children. Am J Cardiol. 2002;89(4):395–398.
  • Nomura A, Zareba W, Moss AJ. Obesity does not influence electrocardiographic parameters in coronary patients. Am J Cardiol. 2000;85(1):106–108.
  • Omran J, Firwana B, Koerber S, et al. Effect of obesity and weight loss on ventricular repolarization: a systematic review and meta-analysis. Obes Rev. 2016;17(6):520–530.
  • Yıldırım Ş, Binnetoğlu FK, Battal F, et al. Relation between QT variables and left ventricular geometry in athletes and obese children. Acta Med Port. 2016;29(2):95–100.
  • Abed HS, Samuel CS, Lau DH, et al. Obesity results in progressive atrial structural and electrical remodeling: implications for atrial fibrillation. Heart Rhythm. 2013;10(1):90–100.
  • Ternacle J, Wan F, Sawaki D, et al. Short-term high-fat diet compromises myocardial function: a radial strain rate imaging study. Eur Heart J Cardiovasc Imaging. 2017;18(11):1283–1291.
  • Sonnenberg GE, Krakower GR, Kissebah AH. A novel pathway to the manifestations of metabolic syndrome. Obes Res. 2004;12(2):180–186.
  • Viazzi F, Piscitelli P, Giorda C, et al. Metabolic syndrome, serum uric acid and renal risk in patients with T2D. PLoS One. 2017;12(4):e0176058.
  • Eisenstein I, Edelstein J, Sarma R, et al. The electrocardiogram in obesity. J Electrocardiol. 1982;15(2):115–118.
  • Tribble DL, Holl LG, Wood PD, et al. Variations in oxidative susceptibility among six low density lipoprotein subfractions of differing density and particle size. Atherosclerosis. 1992;93(3):189–199.
  • Shaw PX. Rethinking oxidized low-density lipoprotein, its role in atherogenesis and the immune responses associated with it. Arch Immunol Ther Exp (Warsz). 2004;52(4):225–239.
  • Phillips LK, Prins JB. The link between abdominal obesity and the metabolic syndrome. Curr Hypertens Rep. 2008;10(2):156–164.
  • Mathieu P, Pibarot P, Larose E, et al. Visceral obesity and the heart. Int J Biochem Cell Biol. 2008;40(5):821–836.
  • Zhang Y, Proenca R, Maffei M, et al. Positional cloning of the mouse obese gene and its human homologue. Nature. 1994;372(6505):425–432.
  • Kelesidis T, Kelesidis I, Chou S, et al. Narrative review: the role of leptin in human physiology: emerging clinical applications. Ann Intern Med. 2010;152(2):93–100.
  • Lollmann B, Gruninger S, Stricker-Krongrad A, et al. Detection and quantification of the leptin receptor splice variants Ob-Ra, b, and, e in different mouse tissues. Biochem Biophys Res Commun. 1997;238(2):648–652.
  • Dyck DJ, Heigenhauser GJ, Bruce CR. The role of adipokines as regulators of skeletal muscle fatty acid metabolism and insulin sensitivity. Acta Physiol (Oxf). 2006;186(1):5–16.
  • Peelman F, Waelput W, Iserentant H, et al. Leptin: linking adipocyte metabolism with cardiovascular and autoimmune diseases. Prog Lipid Res. 2004;43(4):283–301.
  • Lin YK, Chen YC, Huang JH, et al. Leptin modulates electrophysiological characteristics and isoproterenol-induced arrhythmogenesis in atrial myocytes. J Biomed Sci. 2013;20(1):94.
  • Fortuno A, Rodriguez A, Gomez-Ambrosi J, et al. Adipose tissue as an endocrine organ: role of leptin and adiponectin in the pathogenesis of cardiovascular diseases. J Physiol Biochem. 2003;59(1):51–60.
  • Maahs DM, Ogden LG, Kinney GL, et al. Low plasma adiponectin levels predict progression of coronary artery calcification. Circulation. 2005;111(6):747–753.
  • Staiger H, Haring HU. Adipocytokines: fat-derived humoral mediators of metabolic homeostasis. Exp Clin Endocrinol Diabetes. 2005;113(2):67–79.
  • Ouchi N, Kihara S, Arita Y, et al. Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-kappaB signaling through a cAMP-dependent pathway. Circulation. 2000;102(11):1296–1301.
  • Shimabukuro M, Higa N, Asahi T, et al. Hypoadiponectinemia is closely linked to endothelial dysfunction in man. J Clin Endocrinol Metab. 2003;88(7):3236–3240.
  • Denzel MS, Scimia MC, Zumstein PM, et al. T-cadherin is critical for adiponectin-mediated cardioprotection in mice. J Clin Invest. 2010;120(12):4342–4352.
  • Fried SK, Bunkin DA, Greenberg AS. Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: depot difference and regulation by glucocorticoid. J Clin Endocrinol Metab. 1998;83(3):847–850.
  • Guo Y, Lip GY, Apostolakis S. Inflammation in atrial fibrillation. J Am Coll Cardiol. 2012;60(22):2263–2270.
  • Chiu HC, Kovacs A, Blanton RM, et al. Transgenic expression of fatty acid transport protein 1 in the heart causes lipotoxic cardiomyopathy. Circ Res. 2005;96(2):225–233.
  • Hoy AJ, Bruce CR, Turpin SM, et al. Adipose triglyceride lipase-null mice are resistant to high-fat diet-induced insulin resistance despite reduced energy expenditure and ectopic lipid accumulation. Endocrinology. 2011;152(1):48–58.
  • Chow L, From A, Seaquist E. Skeletal muscle insulin resistance: the interplay of local lipid excess and mitochondrial dysfunction. Metab Clin Exp. 2010;59(1):70–85.
  • Birse RT, Bodmer R. Lipotoxicity and cardiac dysfunction in mammals and Drosophila. Crit Rev Biochem Mol Biol. 2011;46(5):376–385.
  • Meade TW, Mellows S, Brozovic M, et al. Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study. Lancet. 1986;2(8506):533–537.
  • Kannel WB, Wolf PA, Castelli WP, et al. Fibrinogen and risk of cardiovascular disease. The Framingham Study. JAMA. 1987;258(9):1183–1186.
  • Stec JJ, Silbershatz H, Tofler GH, et al. Association of fibrinogen with cardiovascular risk factors and cardiovascular disease in the Framingham Offspring Population. Circulation. 2000;102(14):1634–1638.
  • Goldberg RB. Cytokine and cytokine-like inflammation markers, endothelial dysfunction, and imbalanced coagulation in development of diabetes and its complications. J Clin Endocrinol Metab. 2009;94(9):3171–3182.
  • Picano E, Morales MA, del Ry S, et al. Innate inflammation in myocardial perfusion and its implication for heart failure. Ann N Y Acad Sci. 2010;1207:107–115.
  • Galinier M, Pathak A, Roncalli J, et al. [Obesity and cardiac failure]. Arch Mal Coeur Vaiss. 2005;98(1):39–45.
  • Tian M, Dong MQ, Chiu SW, et al. Effects of the antifungal antibiotic clotrimazole on human cardiac repolarization potassium currents. Br J Pharmacol. 2006;147(3):289–297.
  • Aromolaran AS, Boutjdir M. Cardiac ion channel regulation in obesity and the metabolic syndrome: relevance to long QT syndrome and atrial fibrillation. Front Physiol. 2017;8:431.
  • Chang SH, Freeman NLB, Lee JA, et al. Early major complications after bariatric surgery in the USA, 2003–2014: a systematic review and meta-analysis. Obes Rev. 2018;19(4):529–537.
  • Yilmaz M, Altin C, Tekin A, et al. Assessment of atrial fibrillation and ventricular arrhythmia risk after bariatric surgery by P wave/QT interval dispersion. Obes Surg. 2018;28(4):932–938.
  • Al-Salameh A, Allain J, Jacques A, et al. Shortening of the QT interval is observed soon after sleeve gastrectomy in morbidly obese patients. Obes Surg. 2014;24(1):167–170.
  • Grasser EK, Ernst B, Thurnheer M, et al. QT interval shortening after bariatric surgery depends on the applied heart rate correction equation. Obes Surg. 2017;27(4):973–982.
  • Alam I, Lewis MJ, Lewis KE, et al. Influence of bariatric surgery on indices of cardiac autonomic control. Auton Neurosci. 2009;151(2):168–173.
  • Papaioannou A, Michaloudis D, Fraidakis O, et al. Effects of weight loss on QT interval in morbidly obese patients. Obes Surg. 2003;13(6):869–873.
  • Alpert MA, Nusair MB, Mukerji R, et al. Effect of weight loss on ventricular repolarization in normotensive severely obese patients with and without heart failure. Am J Med Sci. 2015;349(1):17–23.
  • Mukerji R, Petruc M, Fresen JL, et al. Effect of weight loss after bariatric surgery on left ventricular mass and ventricular repolarization in normotensive morbidly obese patients. Am J Cardiol. 2012;110(3):415–419.
  • Seshadri P, Samaha FF, Stern L, et al. Free fatty acids, insulin resistance, and corrected qt intervals in morbid obesity: effect of weight loss during 6 months with differing dietary interventions. Endocr Pract. 2005;11(4):234–239.
  • Pietrobelli A, Rothacker D, Gallagher D, et al. Electrocardiographic QTC interval: short-term weight loss effects. Int J Obes Relat Metab Disord. 1997;21(2):110–114.
  • VanHoose L, Sawers Y, Loganathan R, et al. Electrocardiographic changes with the onset of diabetes and the impact of aerobic exercise training in the Zucker Diabetic Fatty (ZDF) rat. Cardiovasc Diabetol. 2010;9(1):56.
  • Surawicz B, Waller BF. The enigma of sudden cardiac death related to dieting. Can J Cardiol. 1995;11(3):228–231.
  • Zuckerman E, Yeshurun D, Goldhammer E, et al. 24 h electrocardiographic monitoring in morbidly obese patients during short-term zero calorie diet. Int J Obes Relat Metab Disord. 1993;17(6):359–361.